AlertWatch gains FDA approval for patient-monitoring software

A startup backed by the University of Michigan says it has received clearance from the US Food and Drug Administration (FDA) to begin selling its patient-monitoring software to hospitals.

AlertWatch (Ann Arbor, MI, USA) – which says its goal is to help anesthesia providers monitor patients in the operating room – has developed software that aggregates data from physiological monitors, anesthesia records, lab results and medical history to produce a real-time display of a patient’s condition.

Its technology continually analyzes data and helps determine whether conditions are normal, marginal or abnormal through the used of colored icons.

“We’ve had a lot of interest from clinicians who have seen the demo,” said Justin Adams, the chief executive of AlertWatch. “Now that we’re over the FDA hurdle, it’ll be great to get the product into their hands.”

AlertWatch has run pilots at a number of universities and plans to begin installing its technology at a several large US hospitals in the near future.

“AlertWatch has made impressive progress in their regulatory requirements and is a great example of the digital health opportunities from the university,” said Ken Nisbet, associate vice president of the University of Michigan Tech Transfer.